Literature DB >> 18472853

Leukocyte activation by (1-->3)-beta-D glucans.

Y Adachi1, M Okazaki, N Ohno, T Yadomae.   

Abstract

We studied the activities of several kinds of beta-glucans, including sonifilan, grifolan, Sclerotinia sclerotiorum glucan, laminarin and zymosan, on macrophages. Preculture of macrophages with inactive beta-glucans rendered the cells unresponsive to subsequent stimulation with grifolan, suggesting a specific pathway in the beta-glucan structure. The importance of protein C and phosphorylation of mitogen-activated protein kinase was demonstrated in the activation with grifolan or zymosan. Immunoprecipitation of complement receptor (CR3), coprecipitated other proteins carrying phosphotyrosine residues in stimulation with grifolan. These data suggest that protein kinase C and tyrosine kinases are essential for signal transduction, and that CR3 might participate in the activation through interaction with other intracellular proteins.

Entities:  

Year:  1997        PMID: 18472853      PMCID: PMC2365869          DOI: 10.1080/09629359791569

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  4 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 2.  Receptor-receptor interactions of complement receptor type 3 in neutrophil membranes.

Authors:  H R Petty; R F Todd
Journal:  J Leukoc Biol       Date:  1993-11       Impact factor: 4.962

Review 3.  Host defense against infections and inflammations: role of the multifunctional IL-6/IFN-beta 2 cytokine.

Authors:  M Revel
Journal:  Experientia       Date:  1989-06-15

4.  Intravenously administered (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 augments murine peritoneal macrophage functions in vivo.

Authors:  T Sakurai; N Ohno; T Yadomae
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-08       Impact factor: 1.645

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.